London Daily

Focus on the big picture.
Tuesday, Oct 07, 2025

Covid vaccine: PM hails Pfizer jab but warns it is 'not game over'

Covid vaccine: PM hails Pfizer jab but warns it is 'not game over'

People should not get "carried away with over optimism" after the UK approved its first coronavirus vaccine, Boris Johnson has warned.

The PM said it did not mean "our struggle is over", saying parts of the economy still faced tough restrictions.

England's deputy chief medical officer Jonathan Van-Tam urged patience over the rollout of the Pfizer/BioNTech jab, which begins early next week.

But care home residents will have to wait due to logistical challenges.

And it could take until April for all those most at-risk to receive the new vaccine, according to the head of NHS England.

A further 648 deaths within 28 days of a positive Covid-19 test were recorded in the UK on Wednesday, with another 16,170 cases reported.

Speaking at a Downing Street news conference, Mr Johnson said the decision to approve the Pfizer jab by regulator MHRA came amid "immense logistical challenges" in getting doses to vulnerable groups.

The vaccine needs to be stored at around -70C and comes in packs of 975 doses, which cannot yet be split into smaller batches.

Those who receive it will need a a second dose 21 days later to receive full protection.

"It's going to continue to be tough for some sectors - but until the vaccine is deployed our plan relies on all of us making sacrifices to protect the ones we love," Mr Johnson said.

Meanwhile, Labour's leader Sir Keir Starmer said the vaccine roll-out would require the "best of Britain" as he called for cross-party consensus on communications about the effort.



This is the day we have been waiting for.

But it is clear listening to NHS England chief executive Simon Stevens and England's deputy chief medical officer Prof Jonathan Van-Tam that huge logistical challenges remain.

First of all, supply. The UK is expecting 800,000 doses in the next few days. But given there are 15 million people over the age of 65 and working in health and care sectors, and all need two doses, getting more into the country is essential.

Millions more doses are promised - but how quickly they arrive remains to be seen.

Roll-out is also difficult. Through a combination of the need to keep the vaccine at ultra-cold storage and the fact that the jab comes in batches of 975 that cannot be split up at the moment, immunisation will only be offered from a network of 50 hospitals to start with.

That's because sending it to care homes, where there may be only a few dozen residents, would lead to a huge amount of vaccine being wasted.

It is why there is still so much hope pinned to the Oxford University vaccine, that regulators are currently reviewing.

That does not need to be kept in ultra-cold storage and so can be distributed much more easily. Plus there are already millions of doses in the country.

Prof Van-Tam said he became emotional when the UK became the first country to approve the Pfizer vaccine, but he too warned that social-distancing rules would have to remain in place.

"If we relax too soon it will create a tidal wave of infections," he said.

"I don't think we are going to eradicate coronavirus ever. I think it's going to be with humankind forever," he added.

Prof Van-Tam also said that those offered the vaccine "must take it".

"We need people to take it. This vaccine isn't going to help you if you don't take it," he said.



NHS England chief executive Sir Simon Stevens said the vaccine would be rolled out to 50 hospital hubs in England, with the over-80s, care home staff and front-line NHS staff being the first to receive it from next week.

Sir Simon said vulnerable people with outpatient appointments scheduled were likely to be among the very first to be offered the jab.

The NHS is "raring to go" to vaccinate people in care homes, hopefully this month, Sir Simon said, but he admitted they would not be among the first to receive it.

Setting out the difficulties faced in getting the vaccine into care homes, he noted that the jab can only be moved a few times, and that each pack of doses cannot be easily split.

The 975 doses they contain would be too many for individual care homes, meaning the vaccine would be wasted, he explained.

Both Pfizer and BioNTech have said the jab can be sent to care homes, as long as the vaccine travels for no more than six hours after it leaves cold storage and is then put in a normal fridge at 2C to 8C.

The Pfizer/BioNTech jab is the fastest vaccine to go from concept to reality, taking only 10 months to follow the steps that normally span 10 years.

The UK has already ordered 40 million doses - enough to vaccinate 20 million people.

These will be rolled out as quickly as they can be made by Pfizer in Belgium, Health Secretary Matt Hancock said earlier, with the first load next week and then "several millions" throughout December.

Scottish First Minister Nicola Sturgeon said the first people in Scotland would be immunised on Tuesday, while Welsh Health and Social Care Minister Vaughan Gething said the roll-out to care homes would be particularly difficult.

The bulk of the roll-out across the UK will be next year.

BioNTech's chief commercial officer Sean Marett said the UK was likely to receive at least 5 million doses of vaccine by the end of the year.

Who gets it?


Sir Simon said most of the at-risk population would be vaccinated between January and March or April.

The order in which people will get the jab has been recommended by the Joint Committee on Vaccinations and Immunisations. But the final decision on who gets the coronavirus vaccine is made by the government.

BBC medical editor Fergus Walsh said Pfizer's plan to get doses to hard-to-reach places such as individual care homes had yet to be approved by the MHRA.

The NHS will begin contacting people about getting vaccinated, with GP practices to work together to operate local vaccination centres.

Aside from the Pfizer vaccine, the UK has options to buy doses of six other candidate jabs. At least four of these have proceeded to phase-three trials.



Boris Johnson: "It will be some months before the most vulnerable are protected"


Newsletter

Related Articles

0:00
0:00
Close
Australia Orders X to Block Murder Videos, Citing Online Safety and Public Exposure
Three Scientists Awarded Nobel Prize in Medicine for Discovery of Immune Self-Tolerance Mechanism
OpenAI and AMD Forge Landmark AI-Chip Alliance with Equity Option
Munich Airport Reopens After Second Drone Shutdown
France Names New Government Amid Political Crisis
Trump Stands Firm in Shutdown Showdown and Declares War on Drug Cartels — Turning Crisis into Opportunity
Surge of U.S. Billionaires Transforms London’s Peninsula Apartments into Ultra-Luxury Stronghold
Pro Europe and Anti-War Babiš Poised to Return to Power After Czech Parliamentary Vote
Jeff Bezos Calls AI Surge a ‘Good’ Bubble, Urges Focus on Lasting Innovation
Japan’s Ruling Party Chooses Sanae Takaichi, Clearing Path to First Female Prime Minister
Sean ‘Diddy’ Combs Sentenced to Fifty Months in Prison Following Prostitution Conviction
Taylor Swift’s ‘Showgirl’ Launch Extends Billion-Dollar Empire
Trump Administration Launches “TrumpRx” Plan to Enable Direct Drug Sales at Deep Discounts
Trump Announces Intention to Impose 100 Percent Tariff on Foreign-Made Films
Altman Says GPT-5 Already Outpaces Him, Warns AI Could Automate 40% of Work
Singapore and Hong Kong Vie to Dominate Asia’s Rising Gold Trade
Trump Organization Teams with Saudi Developer on $1 Billion Trump Plaza in Jeddah
Manhattan Sees Surge in Office-to-Housing Conversions, Highest Since 2008
Switzerland and U.S. Issue Joint Assurance Against Currency Manipulation
Electronic Arts to Be Taken Private in Historic $55 Billion Buyout
Thomas Jacob Sanford Named as Suspect in Deadly Michigan Church Shooting and Arson
Russian Research Vessel 'Yantar' Tracked Mapping Europe’s Subsea Cables, Raising Security Alarms
New York Man Arrested After On-Air Confession to 2017 Parents’ Murders
U.S. Defense Chief Orders Sudden Summit of Hundreds of Generals and Admirals
Global Cruise Industry Posts Dramatic Comeback with 34.6 Million Passengers in 2024
Trump Claims FBI Planted 274 Agents at Capitol Riot, Citing Unverified Reports
India: Internet Suspended in Bareilly Amid Communal Clashes Between Muslims and Hindus
Supreme Court Extends Freeze on Nearly $5 Billion in U.S. Foreign Aid at Trump’s Request
Archaeologists Recover Statues and Temples from 2,000-Year-Old Sunken City off Alexandria
China Deploys 2,000 Workers to Spain to Build Major EV Battery Factory, Raising European Dependence
Speed Takes Over: How Drive-Through Coffee Chains Are Rewriting U.S. Coffee Culture
U.S. Demands Brussels Scrutinize Digital Rules to Prevent Bias Against American Tech
Ringo Starr Champions Enduring Beatles Legacy While Debuting Las Vegas Art Show
Private Equity’s Fundraising Surge Triggers Concern of European Market Shake-Out
Colombian President Petro Vows to Mobilize Volunteers for Gaza and Joins List of Fighters
FBI Removes Agents Who Kneeled at 2020 Protest, Citing Breach of Professional Conduct
Trump Alleges ‘Triple Sabotage’ at United Nations After Escalator and Teleprompter Failures
Shock in France: 5 Years in Prison for Former President Nicolas Sarkozy
Tokyo’s Jimbōchō Named World’s Coolest Neighbourhood for 2025
European Officials Fear Trump May Shift Blame for Ukraine War onto EU
BNP Paribas Abandons Ban on 'Controversial Weapons' Financing Amid Europe’s Defence Push
Typhoon Ragasa Leaves Trail of Destruction Across East Asia Before Making Landfall in China
The Personality Rights Challenge in India’s AI Era
Big Banks Rebuild in Hong Kong as Deal Volume Surges
Italy Considers Freezing Retirement Age at 67 to Avert Scheduled Hike
Italian City to Impose Tax on Visiting Dogs Starting in 2026
Arnault Denounces Proposed Wealth Tax as Threat to French Economy
Study Finds No Safe Level of Alcohol for Dementia Risk
Denmark Investigates Drone Incursion, Does Not Rule Out Russian Involvement
Lilly CEO Warns UK Is ‘Worst Country in Europe’ for Drug Prices, Pulls Back Investment
×